Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Martin

Showing results (461-470 of 653) with videos related to

Pageof 66
Sort By:
Haematologica|November 5, 2020
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphomaTiffany Tang, Peter Martin, Nagavalli Somasundaram, et al.
Human Pathology|December 23, 2014
Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patientsJulia Turbiner Geyer, Shivakumar Subramaniyam, Yanwen Jiang, et al.
Nutrients|April 28, 2025
Ketogenic Diets for Body Weight Loss: A Comparison with Other DietsDamian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, et al.
Trials|October 22, 2021
The 4MOTHERS trial of the impact of a mobile money-based intervention on maternal and neonatal health outcomes in Madagascar: study protocol of a cluster-randomized hybrid effectiveness-implementation trialEtienne Lacroze, Till Bärnighausen, Jan Walter De Neve, et al.
The New England Journal of Medicine|November 5, 2015
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell LymphomaJia Ruan, Peter Martin, Bijal Shah, et al.
Structural Heart : the Journal of the Heart Team|February 9, 2026
Midterm Outcomes of Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation According to Anatomical CharacteristicsDaryoush Samim, Caroline Chong-Nguyen, Yannick Hausammann, et al.
Blood|March 23, 2017
Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapyAjay K Gopal, Brad S Kahl, Christopher R Flowers, et al.
Leukemia & Lymphoma|April 10, 2008
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphomaSarah C Rutherford, Biree Andemariam, Shibu M Philips, et al.
Leukemia & Lymphoma|December 10, 2020
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomasNina D Wagner-Johnston, Stephen J Schuster, Sven deVos, et al.
Swiss Medical Weekly|June 26, 2025
The Swiss Endometriosis Database: a retrospective multicentre cohort study on pain levels and multimodal treatment needs of endometriosis patientsSara Imboden, Selina Lang, Antonalla Martino, et al.
Pageof 66

Showing results (461-470 of 653) with videos related to

Sort By:
Pageof 66
Haematologica|November 5, 2020
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphomaTiffany Tang, Peter Martin, Nagavalli Somasundaram, et al.
Human Pathology|December 23, 2014
Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patientsJulia Turbiner Geyer, Shivakumar Subramaniyam, Yanwen Jiang, et al.
Nutrients|April 28, 2025
Ketogenic Diets for Body Weight Loss: A Comparison with Other DietsDamian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, et al.
Trials|October 22, 2021
The 4MOTHERS trial of the impact of a mobile money-based intervention on maternal and neonatal health outcomes in Madagascar: study protocol of a cluster-randomized hybrid effectiveness-implementation trialEtienne Lacroze, Till Bärnighausen, Jan Walter De Neve, et al.
The New England Journal of Medicine|November 5, 2015
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell LymphomaJia Ruan, Peter Martin, Bijal Shah, et al.
Structural Heart : the Journal of the Heart Team|February 9, 2026
Midterm Outcomes of Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation According to Anatomical CharacteristicsDaryoush Samim, Caroline Chong-Nguyen, Yannick Hausammann, et al.
Blood|March 23, 2017
Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapyAjay K Gopal, Brad S Kahl, Christopher R Flowers, et al.
Leukemia & Lymphoma|April 10, 2008
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphomaSarah C Rutherford, Biree Andemariam, Shibu M Philips, et al.
Leukemia & Lymphoma|December 10, 2020
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomasNina D Wagner-Johnston, Stephen J Schuster, Sven deVos, et al.
Swiss Medical Weekly|June 26, 2025
The Swiss Endometriosis Database: a retrospective multicentre cohort study on pain levels and multimodal treatment needs of endometriosis patientsSara Imboden, Selina Lang, Antonalla Martino, et al.
Pageof 66